TrialBritish journal of clinical pharmacology2022

Pharmacokinetics, pharmacodynamics and safety of BAY 2433334, a novel activated factor XI inhibitor, in healthy volunteers: A randomized phase 1 multiple-dose study.

Dagmar Kubitza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.